July ’s top stories: NCI and COG’s paediatric precision cancer trial, AstraZeneca’s NSCLC trial results
NIH ’s unit NCI and the COG initiated patient enrolment in a paediatric Phase II clinical trial to evaluate targeted cancer medicines, and AstraZeneca reported positive results from the FLAURA trial of Tagrisso to treat patients with locally advanced …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Cancer | Cancer & Oncology | Clinical Trials | Non-Small Cell Lung Cancer | Pediatrics | Pharmaceuticals